Important Background Information on RSV for Pharmacists

Traci M. Poole, PharmD, BCACP, BCGP, discusses the pathophysiology of respiratory syncytial virus (RSV) and its key complications, identifies high-risk populations for severe RSV infection, and explores best practices for recognizing these patients and ensuring they receive timely vaccination to prevent serious outcomes.

Now Viewing

EP: 1.Important Background Information on RSV for Pharmacists

Video content above is prompted by the following:

1. What is the pathophysiology of RSV and the key complications that can arise?
2. Who are the high-risk populations for getting severe RSV infection?
3. What are the best practices for identifying these patients and ensuring that they are vaccinated against RSV?

Related Videos